252 related articles for article (PubMed ID: 7014903)
1. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
Al-Asadi MJ; Towner K; Greenwood D
J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
Reyonolds AV; Hamilton-Miller JM; Brumfitt W
J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
[TBL] [Abstract][Full Text] [Related]
5. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
Ronco E; Migueres ML; Vacheron F; Guenounou M
Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
[TBL] [Abstract][Full Text] [Related]
6. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
Jotzoff M
Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
8. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
Drasar FA; Farrell W; Maskell J; Williams JD
Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
Kabins SA; Nathan C; Cohen S
Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
[TBL] [Abstract][Full Text] [Related]
11. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
[TBL] [Abstract][Full Text] [Related]
12. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
14. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
Moellering RC; Wennersten C; Kunz LJ; Poitras JW
Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Saavedra S; Vera D; Ramírez-Ronda CH
Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
Kosakai N; Oguri T
Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
Skalova R; Hajsig D; Babić I; Mostovac D
Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
[No Abstract] [Full Text] [Related]
18. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
[No Abstract] [Full Text] [Related]
19. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
Briedis DJ; Robson HG
Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
